Annual Cash & Cash Equivalents
$4.59 M
-$15.46 M-77.09%
31 December 2023
Summary:
NRx Pharmaceuticals annual cash & cash equivalents is currently $4.59 million, with the most recent change of -$15.46 million (-77.09%) on 31 December 2023. During the last 3 years, it has risen by +$2.74 million (+147.18%). NRXPW annual cash & cash equivalents is now -83.35% below its all-time high of $27.61 million, reached on 31 December 2021.NRXPW Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$1.65 M
-$252.00 K-13.28%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly cash and cash equivalents is currently $1.65 million, with the most recent change of -$252.00 thousand (-13.28%) on 30 September 2024. Over the past year, it has dropped by -$7.26 million (-81.51%). NRXPW quarterly cash and cash equivalents is now -95.91% below its all-time high of $40.20 million, reached on 31 March 2022.NRXPW Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -77.1% | -81.5% |
| 3 y3 years | +147.2% | -95.8% |
| 5 y5 years | - | +747.2% |
NRXPW Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.3% | +147.2% | -95.9% | +24.8% |
| 5 y | 5 years | -83.3% | >+9999.0% | -95.9% | >+9999.0% |
| alltime | all time | -83.3% | >+9999.0% | -95.9% | >+9999.0% |
NRx Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.65 M(-13.3%) |
| June 2024 | - | $1.90 M(+43.9%) |
| Mar 2024 | - | $1.32 M(-71.3%) |
| Dec 2023 | $4.59 M(-77.1%) | $4.59 M(-48.4%) |
| Sept 2023 | - | $8.90 M(-63.7%) |
| Dec 2022 | $20.05 M(-27.4%) | - |
| June 2022 | - | $24.55 M(-38.9%) |
| Mar 2022 | - | $40.20 M(+45.6%) |
| Dec 2021 | $27.61 M | $27.61 M(-29.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $38.88 M(+190.5%) |
| June 2021 | - | $13.39 M(>+9900.0%) |
| Dec 2020 | $1.86 M(>+9900.0%) | $0.47(+1075.0%) |
| Sept 2020 | - | $0.04(-99.4%) |
| June 2020 | - | $7.00(-100.0%) |
| Mar 2020 | - | $80.77 K(>+9900.0%) |
| Dec 2019 | $6.00 | $6.00(-100.0%) |
| Sept 2019 | - | $194.28 K(>+9900.0%) |
| June 2019 | - | $1394.00(-23.3%) |
| Mar 2019 | - | $1818.00 |
FAQ
- What is NRx Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is NRx Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is NRx Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of NRXPW is $4.59 M
What is the all time high annual cash & cash equivalents for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual cash & cash equivalents is $27.61 M
What is NRx Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, NRXPW annual cash & cash equivalents has changed by -$15.46 M (-77.09%)
What is NRx Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NRXPW is $1.65 M
What is the all time high quarterly cash and cash equivalents for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly cash and cash equivalents is $40.20 M
What is NRx Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, NRXPW quarterly cash and cash equivalents has changed by -$7.26 M (-81.51%)